Most Read This Week
- 2024 Top Story in Metastatic Breast Cancer: Epidemiology of Early vs Late Recurrence Among Women With Early-Stage ER+ Breast Cancer
- 2024 Top Story in Oncology: Triplet Therapy for HR+/HER2− Metastatic Breast Cancer
- Invasive Disease–Free Survival and Brain Metastasis Rates in Patients Treated With Neoadjuvant Chemotherapy With Trastuzumab and Pertuzumab
- Effect of RET Overexpression on Brain Metastatic Competency in Luminal Breast Cancer
- Impact of Molecular Tumor Board Recommendations on Clinical Outcomes in Patients With Metastatic Breast Cancer
Recently Updated
- Assessing the Real-World Effectiveness of Eight Major Metastatic Breast Cancer Drugs Using Target Trial Emulation
- Impact of Molecular Tumor Board Recommendations on Clinical Outcomes in Patients With Metastatic Breast Cancer
- CYP2D6 Activity in Patients With Metastatic Breast Cancer Treated With Single-Agent Tamoxifen
- Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease
- Immune Checkpoint Inhibitors for Patients With Metastatic Inflammatory TNBC